ASTRAZENECA SAYS FARXIGA REDUCED DEATH FROM ANY CAUSE BY 31% IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) IN DAPA-CKD TRIAL
Stock Market News in real time
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
11,992 GBX | +5.64% | +9.69% | 219B | ||
2,888 JPY | -3.73% | -5.16% | 1.29B | ||
- Stock Market
- Stock Market News in real time
- Economy
- Astrazeneca Says Farxiga Reduced Death From Any Cause By 31% In Patients With Chronic Kidney Disease (Ckd) In Dapa-Ckd Trial